Christos Vaklavas

2.9k citations
55 papers · 1.4k indexed · h-index 19

Christos Vaklavas

54 papers receiving 1.4k citations

Peers

Christos Vaklavas
Comparison fields: 5 of 94
  • Oncology 574
  • Cancer Research 304
  • Pulmonary and Respiratory Medicine 278
  • Immunology 167
  • Molecular Biology 525
Replace Ming Jin with:
Ming Jin China
Ala Abudayyeh United States
Gabriele Zoppoli Italy
Genís Campreciós Spain
Amir Mortazavi United States
Antonella Spila Italy
Luigi Di Lauro Italy
Michael Xiang United States
Dale R. Shepard United States
Christos Vaklavas relative to Ming Jin China Ming Jin's profile →
Citations per field
00.5×1.5×1.8×
Ming Jin · 1×
Citations per year

Countries citing papers authored by Christos Vaklavas

Since Specialization
Citations

This map shows the geographic impact of Christos Vaklavas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christos Vaklavas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christos Vaklavas more than expected).

Fields of papers citing papers by Christos Vaklavas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christos Vaklavas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christos Vaklavas. The network helps show where Christos Vaklavas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christos Vaklavas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christos Vaklavas Line = papers co-authored together Christos Vaklavas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 20244
3 20244
4 202316
5 20232
6 20221
7 20212
8 20207
9 2016124
10 201612
11 201575
12 201523
13 20133
14 20135
15 201153
16 201181
17 201039
18 2010138
19 200928
20 200638

About Christos Vaklavas

Christos Vaklavas is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Advanced Breast Cancer Therapies (10 papers), Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (9 papers), Cancer Genomics and Diagnostics (8 papers), Estrogen and related hormone effects (7 papers), Medical Imaging Techniques and Applications (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Oncology (574 citations), Cancer Research (304 citations) and Pulmonary and Respiratory Medicine (278 citations). Christos Vaklavas has collaborated with scholars based in United States, Greece and United Kingdom. Frequent co-authors include Apostolia M. Tsimberidou, Yiannis S. Chatzizisis, Andres Forero‐Torres, George D. Giannoglou, William E. Grizzle, Razelle Kurzrock, Scott W. Blume, Konstantinos C. Koskinas, Apostolos Hatzitolios and Gesthimani Misirli. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026